News Focus
News Focus
Followers 118
Posts 5012
Boards Moderated 4
Alias Born 07/31/2020

Re: Maplelakester post# 45354

Tuesday, 11/11/2025 10:43:01 AM

Tuesday, November 11, 2025 10:43:01 AM

Post# of 45756
I've wondered the same thing.

One would have to think that the Kane & McHenry guys anticipate big upside in the PFD class BKTH shares they are getting in this deal.


However, I also have to wonder if it doesn't relate to the 2023 PR under the terms of the $5M in sales over 5-years. Given they are roughly half way through the contract and given the lack of sales related to BKTH in that time, I have to wonder if Cellhelmet didn't see a value play in selling the company as opposed to a default. Given we know have a good idea who the vendor was in 2023, and given their line of products versus documented sales, we know they likely didn't even come close to reaching the required volume. Just a thought.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y